Kris M. Mahadeo
Duke University(US)
Publications by Year
Research Areas
Hematopoietic Stem Cell Transplantation, CAR-T cell therapy research, Acute Lymphoblastic Leukemia research, Lymphoma Diagnosis and Treatment, Viral-associated cancers and disorders
Most-Cited Works
- → Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like Syndrome(2023)276 cited
- → Management guidelines for paediatric patients receiving chimeric antigen receptor T cell therapy(2018)231 cited
- → Pediatric Acute Lymphoblastic Leukemia, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology(2020)208 cited
- → A Phase 3, Single-Arm, Prospective Study of Remestemcel-L, Ex Vivo Culture-Expanded Adult Human Mesenchymal Stromal Cells for the Treatment of Pediatric Patients Who Failed to Respond to Steroid Treatment for Acute Graft-versus-Host Disease(2020)180 cited
- → Autologous CD33-CAR-T cells for treatment of relapsed/refractory acute myelogenous leukemia(2021)171 cited
- → A pragmatic multi-institutional approach to understanding transplant-associated thrombotic microangiopathy after stem cell transplant(2020)89 cited
- → Invasive Mechanical Ventilation and Mortality in Pediatric Hematopoietic Stem Cell Transplantation(2016)86 cited
- → Diagnosis, grading, and treatment recommendations for children, adolescents, and young adults with sinusoidal obstructive syndrome: an international expert position statement(2019)79 cited
- → IL12 immune therapy clinical trial review: Novel strategies for avoiding CRS-associated cytokines(2022)78 cited
- → Tabelecleucel for allogeneic haematopoietic stem-cell or solid organ transplant recipients with Epstein–Barr virus-positive post-transplant lymphoproliferative disease after failure of rituximab or rituximab and chemotherapy (ALLELE): a phase 3, multicentre, open-label trial(2024)68 cited